Cytarabine Induction Followed by Imatinib Post-Induction Therapy in Patients With Acute Myeloid Leukaemia - Limited Effects in a Case Series

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi - Turkey
doi 10.4999/uhod.11001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Akademi Doktorlar Yayinevi

Related search

Correction To: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

Drugs
Pharmacology
2018English

A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Idarubicin, Cytarabine and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Gynaecomastia in Men With Chronic Myeloid Leukaemia After Imatinib

The Lancet
Medicine
2003English

Acute Myeloid Leukaemia Induced by Mitoxantrone: Case Report

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2005English

Anthracycline Versus Non-Anthracycline Induction Regimens in Patients With De Novo Acute Myeloid Leukemia

Middle East Journal of Internal Medicine
2017English

Analysis of the Interaction of Induction Regimens With P-Glycoprotein Expression in Patients With Acute Myeloid Leukaemia: Results From the MRC AML15 Trial

Blood Cancer Journal
OncologyHematology
2011English

Comment On: Genomics of Primary Chemoresistance and Remission Induction Failure in Paediatric and Adult Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy